Table 2.
Pathogenetic difference of VMTD between TTP and sepsis-associated TTP-like syndrome
TTP (GA-VMTD and AA-VMTD) | TTP-like syndrome in sepsis (EA-VMTD) | |
---|---|---|
Primary event | Hereditary TTP (GA-VMTD) | Sepsis due to pathogens |
(due to mutation of ADAMTSD13 gene) | (e.g., bacteria; viruses; fungi; rickettsia; parasites) | |
Acquired TTP (AA-VMTD) | ↓ | |
(due to anti-ADAMTS13 antibody) | Complement activation → MAC (C5b-9) formation (?) | |
↓ | ↓ | |
Secondary event | Excess of circulating ULVWF & platelets | C5b-9-induced endotheliopathy |
↓ | ↓ | |
Microthrombogenesis, leading to ULVWF-platelet complex formation in microcirculation | ULVWF released from ECs & anchored to endothelial membrane to recruit platelets → microthrombogenesis | |
↓ | ↓ | |
Tertiary event | Microthrombi in microvasculatures | Microthrombi strings in smaller and larger vasculatures |
↓ | ↓ | |
Final event | Microvascular thrombosis | Vascular microthrombosis |
↓ | ↓ | |
GA-VMTD; AA-VMTD | EA-VMTD | |
↓ | ↓ | |
TTP | TTP-like syndrome |
Abbreviations: ECs endothelial cells, MAC membrane attack complex, TTP thrombotic thrombocytopenic purpura, VMTD vascular microhrombotic disease, AA-VMTD antibody-associated VMTD, EA-VMTD endotheliopathy-associated VMTD, ULVWF unusually large von Willebrand factor multimers